CapsoVision (CV) EBT (2024 - 2026)
CapsoVision (CV) posted EBT of -$7.4 million for Q4 2025, up 6.96% sequentially from -$7.9 million in Q3 2025, and down 59.25% YoY from -$18.1 million in Q4 2024.
CapsoVision (CV) EBT (2024 - 2026) Analysis & Trends
CapsoVision has reported EBT for 2 years, with the latest figure at -$7.4 million in Q4 2025.
- Quarterly EBT fell 59.25% year-over-year to -$7.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$24.5 million (changed N/A YoY) and the FY2025 annual result came in at -$25.3 million, down 27.17% from the prior year.
- EBT grew to -$7.4 million in Q4 2025 per CV's latest filing, from -$7.9 million in the prior quarter.
- Over five years, EBT peaked at -$4.6 million in Q2 2025 and troughed at -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.56 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.06 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 519.80 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 317.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 693.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 855.50 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 273.50 Mn |
| 10 | CapsoVision | 295.13 Mn | 286.05 Mn | 1.87 Mn | -7.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.48 Mn |
| Dec 31, 2025 | -7.37 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -5.27 Mn |